产品详情
靶点信息
EGFR | ||||
35 μM |
In vitro | DMSO | 34 mg/mL (182.63 mM) | |
Water | Insoluble | ||
Ethanol | 34 mg/mL (182.63 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 53.71 mL | 268.57 mL | 537.14 mL |
0.5 mM | 10.74 mL | 53.71 mL | 107.43 mL |
1 mM | 5.37 mL | 26.86 mL | 53.71 mL |
5 mM | 1.07 mL | 5.37 mL | 10.74 mL |
*The above data is based on the productmolecular weight 186.17. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A15940 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 186.17 |
Formula | C10H6N2O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 118409-57-7 |
Synonyms | RG-50810, RG-50858, TX 825, Tyrphostin 23, Tyrphostin A23, Tyrphostin AG-18 |
SMILES | N#C/C(C#N)=C/C1=CC=C(O)C(O)=C1 |
产品资料
产品标签
Product Questions
Product Questions
CO-1686 (Rociletinib, AVL-301)
CO-1686是一种新型的口服靶向共价(不可逆)抑制剂,可抑制表皮生长因子受体(EGFR)的致癌突变形式,目…
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
CL-387785 (EKI-785)
CL-387785是EGFR的不可逆抑制剂,IC50为370+/-120 pM;能够在功能水平上克服由T790M突变引起的抗药性。
Neratinib (HKI-272)
Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。
PKC 412 (Midostaurin)
PKC 412 (Midostaurin)是一种广谱蛋白激酶抑制剂。抑制常规PKC亚型α/β/γ,PDFRβ,VEGFR2,Syk,Flk-1,Flt3,Cdk1/B,…